Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor

被引:90
作者
Foster-Cuevas, M [1 ]
Wright, GJ [1 ]
Puklavec, MJ [1 ]
Brown, MH [1 ]
Barclay, AN [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1128/JVI.78.14.7667-7676.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Many viral proteins limit host immune defenses, and their genes often originate from their hosts. CD200 (OX2) is a broadly distributed cell surface glycoprotein that interacts with a receptor on myeloid cells (CD200R) that is implicated in locally preventing macrophage activation. Distant, but recognizable, homologues of CD200 have been identified in many herpesviruses and poxviruses. Here, we show that the product of the K14 open reading frame from human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) interacts with human CD20OR and is expressed at the surfaces of infected cells solely during the lytic cycle. Despite sharing only 40% primary sequence identity, K14 and CD200 interacted with CD200R with an almost identical and low affinity (K-D = 0.5 muM), in contrast to other characterized viral homologue interactions. Cells expressing CD200 or K14 on the cell surface were able to inhibit secretion by activated macrophages of proinflammatory cytokines such as tumor necrosis factor alpha, an effect that could be specifically relieved by addition of monoclonal antibodies and soluble monomeric CD200 protein. We conclude that CD200 delivers local down-modulatory signals to myeloid cells through direct cell-cell contact and that the K14 viral homologue closely mimics this.
引用
收藏
页码:7667 / 7676
页数:10
相关论文
共 44 条
[1]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[2]  
BARCLAY AN, 1981, IMMUNOLOGY, V44, P727
[3]  
BARCLAY AN, 1997, LEUCOCYTE ANTIGENS F
[4]   A sensitive assay for detecting low-affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48 [J].
Brown, MH ;
Preston, S ;
Barclay, AN .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) :3222-3228
[5]   EXPRESSION OF IMMUNOGLOBULIN AND SCAVENGER RECEPTOR SUPERFAMILY DOMAINS AS CHIMERIC PROTEINS WITH DOMAIN-3 AND DOMAIN-4 OF CD4 FOR LIGAND ANALYSIS [J].
BROWN, MH ;
BARCLAY, AN .
PROTEIN ENGINEERING, 1994, 7 (04) :515-521
[6]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090
[7]  
BUKOVSKY A, 1983, IMMUNOLOGY, V48, P587
[8]   Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? [J].
Cesarman, E ;
Mesri, EA ;
Gershengorn, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (03) :417-421
[9]   The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 [J].
Chapman, TL ;
Heikema, AP ;
Bjorkman, PJ .
IMMUNITY, 1999, 11 (05) :603-613
[10]   Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus [J].
Chiou, CJ ;
Poole, LJ ;
Kim, PS ;
Ciufo, DM ;
Cannon, JS ;
ap Rhys, CM ;
Alcendor, DJ ;
Zong, JC ;
Ambinder, RF ;
Hayward, GS .
JOURNAL OF VIROLOGY, 2002, 76 (07) :3421-3439